Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity
Dengue is one of the most frequently transmitted mosquito-borne diseases in the world, which creates a significant public health concern globally, especially in tropical and subtropical countries. It is estimated that more than 390 million people are infected with dengue virus each year and around 9...
Main Authors: | Abdullah M. Izmirly, Sana O. Alturki, Sawsan O. Alturki, Jennifer Connors, Elias K. Haddad |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01055/full |
Similar Items
-
The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
by: Sana O. Alturki, et al.
Published: (2020-08-01) -
T follicular helper cell subsets: a potential key player in autoimmunity
by: Izumi Kurata, et al.
Published: (2021-01-01) -
Evaluation of serum adenosine deaminase and its isoenzymes in patients with ovarian cancer
by: A. Asadi, et al.
Published: (2018-07-01) -
Adenosine Deaminase Activity in COPD Patients and Healthy Subjects
by: Mohammad Taghi Goodarzi, et al.
Published: (2010-03-01) -
Usefulness of Adenosine Deaminase Assay in Diagnosis of Patients with HIV Infection and Pleural Tuberculosis
by: Gabriel Yusti, et al.
Published: (2018-11-01)